


Healthcare News Roundup: Acquisition
HSMN NewsFeed - 17 Jun 2019
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize anti-CD19 T-cell Therapy
HSMN NewsFeed - 12 Jun 2019
CutisPharma Announces Acquisition Of Silvergate Pharmaceuticals, Name Change To Azurity Pharmaceuticals
CutisPharma Announces Acquisition Of Silvergate Pharmaceuticals, Name Change To Azurity Pharmaceuticals
HSMN NewsFeed - 14 May 2019
CrossRoads Extremity Systems and HealthpointCapital Announce Merger Agreement
CrossRoads Extremity Systems and HealthpointCapital Announce Merger Agreement
